WorldPharma giants push for tariff clarity as ambiguity threatens EU-U.S. deal Last updated: July 29, 2025 3:18 pm TARESH SINGH Share 0 Min Read SHARE The pharma sector remains under a U.S. Section 232 investigation, with the outcome due by August.Related ‘Not even an inch given to China’: Kiren Rijiju in Parliament The index to watch to decide if we are entering a new bull phase Australia’s second-quarter inflation drops to lowest since March 2021, supporting case for rate cut US sanctions Cuban president, ‘regime-controlled’ luxury hotels BJP-Sena turf war escalates: MoS Misal, minister Shirsat clash over authority; Fadnavis steps in Share This Article Facebook Pinterest Whatsapp Whatsapp LinkedIn Telegram Threads Copy Link Print Share Previous Article Sanjay Dutt’s first look from ‘The Raja Saab’ out Next Article How to properly water and care for your plants before leaving for a vacation Leave a Comment Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment *Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Latest News KL was once a ‘third wheel’ on Anushka-Virat’s date Entertainment July 30, 2025 Bihar: Nitish Kumar announces 3x pay hike for Asha workers; Mamta incentives doubled July 30, 2025 HSBC second-quarter profit plunges 29%, missing expectations World July 30, 2025 ‘Saiyaara’ crosses Rs 400 crore worldwide Entertainment July 30, 2025 Google news feed
